Trokide Vertical-Haler

Trokide Vertical-Haler® is a dry powder inhaler (DPI) which is therapeutically equivalent to Spiriva® HandiHaler® for formulation and device characteristics.1,2

Trokide® (tiotropium bromide) indications1

Trokide Vertical-Haler® is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).

Instructions for reporting Adverse Events can be found in the footer of this page. Prescribing information is available here.

trokide inhaler photograph

Unlock Savings With Trokide®

Save up to 71% annually for the NHS vs other tiotropium bromide inhalers.3

*Savings based on indicative NHS list prices.3

Request cost-savings report

Equivalence to Spiriva® HandiHaler®

Trokide Vertical-Haler® is equivalent to Spiriva® HandiHaler® in terms of:2

  • active ingredient
  • delivered dose per actuation
  • inhaling technique
  • therapeutic effect and device characteristics

Demonstration devices are also available

Request demo devices

Trokide device

Device Characteristics
1. Cap  |  2. Mouthpiece  |  3. Base
4. Push button  |  5. Capsule chamber/nest

Implementation Support

We’re here to support you all the way through the implementation process, with formulary support documents, cost calculators for your area, letters as well as materials for both healthcare professionals and patients.

Committed to measuring and reducing carbon emissions

STADA UK is committed to reducing carbon emissions for Trokide Vertical-Haler® using industry emissions as a benchmark.

Trokide Vertical-Haler® is a dry-powder inhaler. Increasing use of DPIs instead of pMDIs (pressurised metered dose inhaler) helps to reduce CO2 emissions for the NHS.4

References

  1. Trokide® Prescribing Information. Accessed: November 2026.
  2. STADA UK Ltd. 2024. Data on File. Trokide Pharmaceutical Development.
  3. BNF.  Tiotropium: Medicinal forms. Accessed: November 2026.
  4. NHS England. 2021. Delivering a ‘Net Zero’ National Health Service. Accessed: November 2026.
  5. Teva UK Ltd. 2019. Summary of Product Characteristics. Braltus Tiotropium (Braltus) 10mcg inhalation powder. Accessed: November 2026.

 

The information in this website is intended solely for UK Healthcare Professionals and contains promotional information.

I confirm I am a UK Healthcare Professional

UK Patients – If you have been prescribed one of our products by a UK healthcare professional, you can visit the dedicated patient sites for more information: Trokide® | Proxor® | Fixkoh®

Other visitors – Please visit our main web site.

UK-MULT-307(1) | July 2025

The information in this website is intended solely for UK Healthcare Professionals and contains promotional information.

I confirm I am a UK Healthcare Professional

UK Patients – If you have been prescribed one of our products by a UK healthcare professional, you can visit the dedicated patient sites for more information: Trokide® | Proxor® | Fixkoh®

Other visitors – Please visit our main web site.

UK-MULT-307(1) | July 2025

The information in this website is intended solely for UK Healthcare Professionals and contains promotional information.

I confirm I am a UK Healthcare Professional

UK Patients – If you have been prescribed one of our products by a UK healthcare professional, you can visit the dedicated patient sites for more information: Trokide® | Proxor® | Fixkoh®

Other visitors – Please visit our main web site.

UK-MULT-307(1) | July 2025

The information in this website is intended solely for UK Healthcare Professionals and contains promotional information.

I confirm I am a UK Healthcare Professional

UK Patients – If you have been prescribed one of our products by a UK healthcare professional, you can visit the dedicated patient sites for more information: Trokide® | Proxor® | Fixkoh®

Other visitors – Please visit our main web site.

UK-MULT-307(1) | July 2025

Trokide® (tiotropium bromide) indications1

Trokide Vertical-Haler® is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).